Literature DB >> 18799235

Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters.

S T Heo1, S J Kim, Y G Jeong, I G Bae, J S Jin, J C Lee.   

Abstract

Burkholderia cepacia complex (BCC) is an opportunistic pathogen that occasionally causes hospital outbreaks. This paper describes an outbreak of BCC bacteraemia in haematological malignancy patients related to a contaminated chlorhexidine gluconate solution. Eight BCC isolates were obtained from patients hospitalised in the same ward of a cancer centre in a Korean hospital. A further three BCC isolates were obtained from 0.5% chlorhexidine gluconate used in the same ward. The isolates were identified as B. stabilis and exhibited identical pulsed-field gel electrophoresis profiles. All patients with B. stabilis bacteraemia had indwelling intravenous catheters, which were treated with chlorhexidine to disinfect the catheters. Following identification of the source of contamination, strict controls regarding surveillance cultures for disinfectants have been enforced. No further B. stabilis infections have been found in the hospital.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799235     DOI: 10.1016/j.jhin.2008.07.019

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  Antibiotic resistance profile of non-fermenting Gram-negative bacilli isolated from the blood cultures of cancer patients.

Authors:  Frincy K Baruah; Ahmed Nishat Hussain; Rajesh K Grover
Journal:  J Glob Infect Dis       Date:  2015 Jan-Mar

2.  [Outbreak of Burkholderia cepacia complex caused by contaminated alcohol-free mouthwash].

Authors:  M Martin; I Winterfeld; E Kramme; I Ewert; B Sedemund-Adib; F Mattner
Journal:  Anaesthesist       Date:  2012-01-25       Impact factor: 1.041

3.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

4.  Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Julian A Gatta; Nozomi Ohuchi; Robert A Bonomo; Michiyoshi Nukaga
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

5.  Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Authors:  David E Greenberg; Kimberly R Marshall-Batty; Lauren R Brinster; Kol A Zarember; Pamela A Shaw; Brett L Mellbye; Patrick L Iversen; Steven M Holland; Bruce L Geller
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  Antimicrobial Susceptibility Pattern of Burkholderia cepacia Isolates from Patients with Malignancy.

Authors:  Priyamvada Roy; Nishat Hussain Ahmed; Indu Biswal; Rk Grover
Journal:  J Glob Infect Dis       Date:  2014-04

7.  Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Microbiol       Date:  2011-07-22       Impact factor: 5.640

8.  A demonstration of the susceptibility of clinical isolates obtained from cystic fibrosis patients to manuka honey.

Authors:  Rowena Jenkins; Mandy Wootton; Robin Howe; Rose Cooper
Journal:  Arch Microbiol       Date:  2015-02-14       Impact factor: 2.552

Review 9.  Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2011-07-22       Impact factor: 5.293

10.  Polyclonal outbreak of bloodstream infections caused by Burkholderia cepacia complex in hematology and bone marrow transplant outpatient units.

Authors:  Icaro Boszczowski; Gladys Villas Boas do Prado; Mirian F Dalben; Roberto C P Telles; Maristela Pinheiro Freire; Thaís Guimarães; Maura S Oliveira; Juliana F Rosa; Robson E Soares; Pedro Enrique Dorlhiac Llacer; Frederico Luiz Dulley; Silvia F Costa; Anna S Levin
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.